[Beta-defensin 2: an update].
Fang
Xiang-min
XM
Department of Anaesthesiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. xiangming_fang@163.com
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D015703:Antigens, CD / Q000276:immunology; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D011110:Polymorphism, Genetic; D011994:Recombinant Proteins / Q000494:pharmacology; D051197:Toll-Like Receptor 4 / Q000378:metabolism; D023083:beta-Defensins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*
D000890:Anti-Infective Agents; D015703:Antigens, CD; C106641:DEFB4A protein, human; D011994:Recombinant Proteins; D051197:Toll-Like Receptor 4; D023083:beta-Defensins